Vanda Pharmaceuticals
VNDA
#8239
Rank
NZ$0.53 B
Marketcap
NZ$8.95
Share price
-3.36%
Change (1 day)
13.61%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2026 (TTM): NZ-$6.96

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$7.00. In 2025 the company made an earnings per share (EPS) of NZ-$6.44 a decrease over its 2024 EPS that were of NZ-$0.55.

EPS history for Vanda Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$6.968.05%
2025NZ-$6.441065.63%
2024NZ-$0.55-710.9%
2023NZ$0.09048-56.35%
2022NZ$0.21-80%
2021NZ$1.04
2019NZ$3.75334%
2018NZ$0.86-247.06%
2017NZ-$0.59-19.05%
2016NZ-$0.73-55.32%
2015NZ-$1.62-347.37%
2014NZ$0.66-156.72%
2013NZ-$1.16-31.63%
2012NZ-$1.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.09-315.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.13-273.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.26-132.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.76-796.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.18-188.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.15-187.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
NZ-$7.58 8.40%๐Ÿ‡บ๐Ÿ‡ธ USA